Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Theravance Biopharma
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male or female between 18 to 55 years old
Male subjects must abstain from sexual intercourse or use a highly effective method of birth control
Women of child bearing potential must have a negative pregnancy test and either abstain from sex or use a highly effective method of birth control
Body Mass Index (BMI) 18 to 32 kg/m2
Willing and able to give informed consent
Subject has a history of UC
Subject is either not taking any medication for UC or has been taking a stable dose of ulcerative colitis medications for ≥ 14 days
You may not be if
Is positive for hepatitis A, B or C, HIV or tuberculosis
Has clinically significant abnormalities in baseline laboratory evaluations
Subject has a clinically significant abnormal electrocardiogram (ECG)
Participated in another clinical trial of an investigational drug (or medical device) within 30 days prior to screening (or within 60 days prior to screening if investigational drug was a biologic, or is currently participating in another trial of an investigational drug (or medical device)
Use of prescription drugs or any chronic over the counter medications within 14 days prior to clinic admission or requires continuing use during study participation, with the exception of hormonal contraceptives or hormone replacement therapy or standard daily multivitamin.
